Slide 1: Cegedim 9M 2014
es cegedim 9M 2014 1. . jae’ “STRATEGY a Strength
Slide 2: Safe Harbor Statement
Safe Harbor This presentation contains forward-looking Statement statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward- looking statements involve risk and uncertainty. Forward-looking statements represent the comp
Slide 3: Business & Strategy Review
EE STRATE SS & Strategy Review eu cegedim
Slide 4: First 9M 2014 Takeaways
First 9M 2014 Takeaways This document should not be distributed without Cegedim authorization – Copyright 2014 4
Slide 5: First Nine Months 2014 Key Figures
First Nine Months 2014 Key Figures This document should not be distributed without Cegedim authorization – Copyright 2014 5
Slide 6: CRM & Strategic Data Review
CRM & Strategic Data Review Significant currency negative impact Positive Impact on EBITDA from: • Compliance activities • OneKey database-related products Improvement of profitability of market research activity during the first 9 months This document should not be distributed without Cegedim autho
Slide 7: Healthcare Professionals Review
Healthcare Professionals Review • Less demanding comparison level for UK doctors software • Improvement on margin from software for pharmacists activity in France in Q3 • Robust growth in France in products for paramedical professions (nurses, …) • Positive development of RNP activity This document
Slide 8: Insurance & Services Review
Insurance & Services Review • Transition from a perpetual license model to a SaaS model at Cegedim Global Payments • Significant investment in Kadrige • Profitability increase thanks to: • Activity for Health Insurance companies • Cegedim SRH This document should not be distributed without Cegedim a
Slide 9: GERS Activities & Reconciliation Review
GERS Activities & Reconciliation Review Favorable trend in EBITDA reflects the virtual stability of corporate costs and the gradual return to breakeven at GERS activities This document should not be distributed without Cegedim authorization – Copyright 2014 9
Slide 10: 2014 Outlook
2014 Outlook This document should not be distributed without Cegedim authorization – Copyright 2014 10
Slide 11: Definitive Purchase Agreement Executed
Definitive Purchase Agreement Executed This document should not be distributed without Cegedim authorization – Copyright 2014 11
Slide 12: Next Steps on IMS Health Transaction
Next Steps on IMS Health Transaction This document should not be distributed without Cegedim authorization – Copyright 2014 12
Slide 13: IMS Health Transaction: FAQ
IMS Health Transaction: FAQ This document should not be distributed without Cegedim authorization – Copyright 2014 13
Slide 14: The New Cegedim
Bt ceed The New Cegedim © INSURANCE Revenue « & SERVICES arouiid oHEALTNCARE aS SUEARE €482m EBITDA around €90m e Leading Position: in France, Italy, Spain are: in UK and France EBITDA Margin OFFERS around : 20% FLOW FS PTT ES EBIT HR SERVICES around m €160m. Leverage Ratio around Group EBIT* X1.0 B
Slide 15: First Nine Months 2014 Financial Situation
First Nine Months 2014 Financial Situation
Slide 16: Revenue Evolution per Division
Revenue Evolution per Division This document should not be distributed without Cegedim authorization – Copyright 2014 16
Slide 17: From Revenue to EBITDA
From Revenue to EBITDA This document should not be distributed without Cegedim authorization – Copyright 2014 17
Slide 18: EBITDA per Division
EBITDA per Division This document should not be distributed without Cegedim authorization – Copyright 2014 18
Slide 19: From EBITDA to EBIT
From EBITDA to EBIT This document should not be distributed without Cegedim authorization – Copyright 2014 19
Slide 20: From EBIT to Net Profit
From EBIT to Net Profit This document should not be distributed without Cegedim authorization – Copyright 2014 20
Slide 21: Robust Financial Structure
Robust Financial Structure This document should not be distributed without Cegedim authorization – Copyright 2014 21
Slide 22: Net Debt Trend
Net Debt Trend This document should not be distributed without Cegedim authorization – Copyright 2014 22
Slide 23: Strong Liquidity Position
Strong Liquidity Position This document should not be distributed without Cegedim authorization – Copyright 2014 23
Slide 24: Next Events
Next Events This document should not be distributed without Cegedim authorization – Copyright 2014 24
Slide 25: Our IR App is now available
Our IR App is now available This document should not be distributed without Cegedim authorization – Copyright 2014 25
Slide 26: Appendix
Appendix Innovation STRATEGY Strength ih. : eu cegedim
Slide 27: Revenue & Organic Growth Calculation
Revenue & Organic Growth Calculation CRM & Strategic Healthcare Insurance & GERS Activities & Q3‐2014 Group Data Professionals Services Reconciliation Q3 2013 Revenue a 100,193 66,016 37,617 7,188 211,014 Impact of disposals 0 0 0 0 0 Q3 2013 Revenue before impact of disposals 100,193 66,016 37,617
Slide 28: 2015 Financial Agenda
2015 Financial Agenda This document should not be distributed without Cegedim authorization – Copyright 2014 28
Slide 29: We welcome your questions and comments
We welcome your questions and comments Jan Eryk UMIASTOWSKI Chief Investment Officer Head of Investor Relations Janeryk.umiastowski@cegedim.com www.cegedim.com/finance TEL: +33 (0) 1 49 09 33 36